GAITHERSBURG, Md.--(BUSINESS WIRE)--Sept. 8, 2006--GenVec, Inc. (Nasdaq:GNVC) announced today that Stelios Papadopoulos, Ph.D., a member of the GNVC Board of Directors since 2003, will be leaving the Board effective as of its next regularly scheduled meeting in October 2006. Prior to joining the GenVec Board, he was a Director of Diacrin from 1991-2003. GenVec acquired Diacrin in 2003. Dr. Papadopoulos, who recently announced his resignation as a Vice Chairman of Cowen and Company, LLC, has decided to pursue other interests and expects to resign from a number of other boards of directors on which he currently serves.
